Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Determinants of Smoking and Quitting in HIV-Infected Individuals.

Regan S, Meigs JB, Grinspoon SK, Triant VA.

PLoS One. 2016 Apr 21;11(4):e0153103. doi: 10.1371/journal.pone.0153103. eCollection 2016.

2.

HIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formation.

Bernard MA, Han X, Inderbitzin S, Agbim I, Zhao H, Koziel H, Tachado SD.

PLoS One. 2014 Aug 4;9(8):e104039. doi: 10.1371/journal.pone.0104039. eCollection 2014.

3.

Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda.

Ssinabulya I, Kayima J, Longenecker C, Luwedde M, Semitala F, Kambugu A, Ameda F, Bugeza S, McComsey G, Freers J, Nakanjako D.

PLoS One. 2014 Feb 28;9(2):e89537. doi: 10.1371/journal.pone.0089537. eCollection 2014.

4.

Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.

Fitch K, Grinspoon S.

Am J Clin Nutr. 2011 Dec;94(6):1721S-1728S. doi: 10.3945/ajcn.111.012120. Epub 2011 Nov 16. Review.

5.

Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women.

Schwartz RM, Mansoor A, Wilson TE, Anastos K, Everson-Rose SA, Golub ET, Goparaju L, Hessol NA, Mack WJ, Lazar J.

AIDS Care. 2012;24(3):394-403. doi: 10.1080/09540121.2011.608791. Epub 2011 Sep 9.

6.

HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.

Gibellini D, Alviano F, Miserocchi A, Tazzari PL, Ricci F, Clò A, Morini S, Borderi M, Viale P, Pasquinelli G, Pagliaro P, Bagnara GP, Re MC.

Retrovirology. 2011 May 25;8:40. doi: 10.1186/1742-4690-8-40.

7.

Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease.

Butt AA, Chang CC, Kuller L, Goetz MB, Leaf D, Rimland D, Gibert CL, Oursler KK, Rodriguez-Barradas MC, Lim J, Kazis LE, Gottlieb S, Justice AC, Freiberg MS.

Arch Intern Med. 2011 Apr 25;171(8):737-43. doi: 10.1001/archinternmed.2011.151.

8.

Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem.

Gopal M, Bhaskaran A, Khalife WI, Barbagelata A.

Curr Cardiol Rev. 2009 May;5(2):149-54. doi: 10.2174/157340309788166705.

9.

Arterial wave reflection in HIV-infected and HIV-uninfected Rwandan women.

Lazar JM, Wu X, Shi Q, Kagame A, Cohen M, Binagwaho A, Munyakazi L, Salciccioli L, Shi D, Anastos K.

AIDS Res Hum Retroviruses. 2009 Sep;25(9):877-82. doi: 10.1089/aid.2008.0269.

10.

Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges.

Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):54-64. doi: 10.1521/aeap.2009.21.3_supp.54.

11.

Prevention of atherosclerosis in patients living with HIV.

De Lorenzo F, Boffito M, Collot-Teixeira S, Gazzard B, McGregor JL, Shotliff K, Xiao H.

Vasc Health Risk Manag. 2009;5(1):287-300. Epub 2009 Apr 8.

12.

Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):369-76.

13.

Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB Sr, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; Working Group 5.

Circulation. 2008 Jul 8;118(2):e48-53. doi: 10.1161/CIRCULATIONAHA.107.189627. Epub 2008 Jun 19. No abstract available.

14.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.

15.

Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.

Johnsen S, Dolan SE, Fitch KV, Kanter JR, Hemphill LC, Connelly JM, Lees RS, Lee H, Grinspoon S.

J Clin Endocrinol Metab. 2006 Dec;91(12):4916-24. Epub 2006 Sep 26.

16.

Endothelial function in HIV-infected persons.

Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, Horsburgh CR Jr.

Clin Infect Dis. 2006 May 1;42(9):1325-32. Epub 2006 Mar 31.

Supplemental Content

Support Center